Tevogen announces 50-for-1 reverse stock split

Tevogen’s (TVGN) Board of Directors has approved a reverse stock split of its common stock at a ratio of 50 for 1. Stockholders previously approved the reverse stock split on February 19, 2026, and provided the Board with discretion to determine the final reverse stock split ratio. The reverse stock split is being conducted to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Global Market and is expected to become effective at 12:01 a.m. on March 6. The Company’s common stock is expected to begin trading on Nasdaq on a split-adjusted basis as of the beginning of trading on March 6, under the same symbol, “TVGN”, and a new CUSIP number, 88165K 200.